6-6-2018An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens o…
5-18-2018As a result of the many scientific research advances over 37 years, we now have highly effective methods of HIV treatment and prevention. These tools have allow…
11-8-2017
Cross-posted from NIAID Newsroom
Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likel…
7-24-2017The International AIDS Society Conference on HIV Science (IAS 2017) continued in Paris today, and Dr. Carl Dieffenbach shared some of the conference’s res…
7-24-2017Crossposted from NIAID Newsroom
Results From Early-Stage NIH-Funded Trial Support Further Development of Candidate VaccinesDr. Dan Barouch presen…
7-23-2017The International AIDS Society Conference on HIV Science (IAS 2017) got underway in Paris on Sunday. As it began, Dr. Anthony Fauci, Director of NIH’s Nat…
5-20-2017In the three decades since the first cases of AIDS were reported, Federal investments in basic, biomedical, behavioral, and social science research have led to …
1-9-2017It is fitting that in the year that we marked the 35th anniversary of the first recognition of what would come to be known as HIV, we’ve taken major steps…
